Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.
      Google Scholar   
Citation:
J Clin Oncol vol 41 (33) 5118-30
Year:
2023
Type:
Manuscript
Funding:
AFT
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
3730  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Pfizer  
Grants:
AFT, ABCSG, in cooperation with PrECOG, BIG, GBG, NSABP  
Corr. Author:
 
Authors:
                                                                                                       
Networks:
CAPITAL, FL086, LAPS-CT018, LAPS-MA036, LAPS-MD017, LAPS-MN026, LAPS-PA015, UPSTATE   
Study
AFT-05
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: